Michael Elliot

Michael Elliot is a Senior Research Scientist at Achillion Pharmaceuticals, Inc. since 2012, specializing in metabolic stability screening for discovery programs and managing workload to ensure timely results. Previously, Michael served as a Senior Research Investigator and Research Investigator at Sanofi from 2005 to 2012, overseeing screening and candidate profiling assays related to Cytochrome P450 inhibition. Michael began a career as Scientist II at Aventis Pharmaceuticals from 2000 to 2005, focusing on mechanism-based inhibition assays and various analyses. Michael holds a BSc in Medical Biochemistry from the University of Surrey and an MSc in Pharmacology and Toxicology from the University of Hertfordshire.